CA
RXDX
CHI Advisors’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-934,135
| Closed | -$100M | – | 30 |
|
|
2023
Q1 | $100M | Buy |
934,135
+10,335
| +1% | +$1.11M | 26.61% | 1 |
|
|
2022
Q4 | $102M | Sell |
923,800
-677,985
| -42% | -$74.6M | 27.06% | 1 |
|
|
2022
Q3 | $94.5M | Sell |
1,601,785
-70,191
| -4% | -$4.14M | 25.42% | 1 |
|
|
2022
Q2 | $47.2M | Buy |
1,671,976
+86,880
| +5% | +$2.45M | 18.03% | 1 |
|
|
2022
Q1 | $59.9M | Sell |
1,585,096
-167,147
| -10% | -$6.31M | 25.45% | 1 |
|
|
2021
Q4 | $69.3M | Sell |
1,752,243
-1,109,816
| -39% | -$43.9M | 23% | 1 |
|
|
2021
Q3 | $67.9M | Buy |
2,862,059
+10,050
| +0.4% | +$238K | 19.81% | 1 |
|
|
2021
Q2 | $70M | Sell |
2,852,009
-22,023
| -0.8% | -$541K | 16.29% | 2 |
|
|
2021
Q1 | $52.5M | Buy |
+2,874,032
| New | +$52.5M | 10.51% | 4 |
|